KR20230028706A - Antimicrobial wipes that emit far-infrared radiation - Google Patents
Antimicrobial wipes that emit far-infrared radiation Download PDFInfo
- Publication number
- KR20230028706A KR20230028706A KR1020220096427A KR20220096427A KR20230028706A KR 20230028706 A KR20230028706 A KR 20230028706A KR 1020220096427 A KR1020220096427 A KR 1020220096427A KR 20220096427 A KR20220096427 A KR 20220096427A KR 20230028706 A KR20230028706 A KR 20230028706A
- Authority
- KR
- South Korea
- Prior art keywords
- fatty acids
- omega
- wet tissue
- fatty acid
- catechin
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title abstract description 3
- 230000005855 radiation Effects 0.000 title description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 27
- 229930195729 fatty acid Natural products 0.000 claims abstract description 27
- 239000000194 fatty acid Substances 0.000 claims abstract description 27
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 26
- 235000005487 catechin Nutrition 0.000 claims abstract description 17
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims abstract description 17
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 16
- 229950001002 cianidanol Drugs 0.000 claims abstract description 16
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 14
- 239000004744 fabric Substances 0.000 claims abstract description 10
- 229920003002 synthetic resin Polymers 0.000 claims abstract description 5
- 239000000057 synthetic resin Substances 0.000 claims abstract description 5
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 14
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 claims description 7
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 7
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 7
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 5
- 235000014620 theaflavin Nutrition 0.000 abstract description 9
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 abstract description 7
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 abstract description 7
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 abstract description 7
- 229940026509 theaflavin Drugs 0.000 abstract description 7
- 230000000840 anti-viral effect Effects 0.000 abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 229940012843 omega-3 fatty acid Drugs 0.000 description 11
- 244000269722 Thea sinensis Species 0.000 description 10
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 10
- 239000006014 omega-3 oil Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 235000006468 Thea sinensis Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 229940033080 omega-6 fatty acid Drugs 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000004743 Polypropylene Substances 0.000 description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 5
- 230000003385 bacteriostatic effect Effects 0.000 description 5
- 235000020279 black tea Nutrition 0.000 description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- -1 polypropylene Polymers 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 239000000284 extract Substances 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000021003 saturated fats Nutrition 0.000 description 3
- 235000021081 unsaturated fats Nutrition 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- GPLOTACQBREROW-UHFFFAOYSA-N Phlegmanol A-acetat Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC1=2)C=C(O)C(=O)C1=C(O)C(O)=CC=2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GPLOTACQBREROW-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- KMJPKUVSXFVQGZ-UHFFFAOYSA-N TF2B Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 KMJPKUVSXFVQGZ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- JXNPEDYJTDQORS-HZJYTTRNSA-N (9Z,12Z)-octadecadien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCO JXNPEDYJTDQORS-HZJYTTRNSA-N 0.000 description 1
- 239000001195 (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid Substances 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000056974 Adansonia digitata Species 0.000 description 1
- 235000003320 Adansonia digitata Nutrition 0.000 description 1
- 235000003319 Adansonia gregorii Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- BVMDSEFJGKQBKJ-UHFFFAOYSA-N Theaflavin 3'-gallate Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O BVMDSEFJGKQBKJ-UHFFFAOYSA-N 0.000 description 1
- KMJPKUVSXFVQGZ-WQLSNUALSA-N [(2r,3r)-5,7-dihydroxy-2-[3,4,5-trihydroxy-6-oxo-1-[(2r,3r)-3,5,7-trihydroxy-3,4-dihydro-2h-chromen-2-yl]benzo[7]annulen-8-yl]-3,4-dihydro-2h-chromen-3-yl] 3,4,5-trihydroxybenzoate Chemical compound O([C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=CC(=O)C(O)=C2C(O)=C(O)C=C(C2=C1)[C@H]1OC2=CC(O)=CC(O)=C2C[C@H]1O)C(=O)C1=CC(O)=C(O)C(O)=C1 KMJPKUVSXFVQGZ-WQLSNUALSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- JXNPEDYJTDQORS-UHFFFAOYSA-N linoleyl alcohol Natural products CCCCCC=CCC=CCCCCCCCCO JXNPEDYJTDQORS-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000010507 melon oil Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- IKLDTEFDTLKDRK-UHFFFAOYSA-N theaflavin 3'-gallate Natural products OC1Cc2c(O)cc(O)cc2OC1c3cc4C=C(C=C(O)C(=O)c4c(O)c3O)C5Oc6cc(O)cc(O)c6CC5OC(=O)c7cc(O)c(O)c(O)c7 IKLDTEFDTLKDRK-UHFFFAOYSA-N 0.000 description 1
- AATSUYYYTHJRJO-UHFFFAOYSA-N theaflavin 3-gallate Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(=CC(=O)C(O)=C1C(O)=C2O)C=C1C=C2C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-UHFFFAOYSA-N 0.000 description 1
- 235000002365 theaflavin-3'-gallate Nutrition 0.000 description 1
- 235000007900 theaflavin-3-gallate Nutrition 0.000 description 1
- AATSUYYYTHJRJO-RZYARBFNSA-N theaflavin-3-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(O)C=C2O[C@@H]1C1=C(O)C(O)=C2C(=O)C(O)=CC(=CC2=C1)[C@H]1OC2=CC(O)=CC(O)=C2C[C@H]1O)C(=O)C1=CC(O)=C(O)C(O)=C1 AATSUYYYTHJRJO-RZYARBFNSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47K—SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR; TOILET ACCESSORIES
- A47K7/00—Body washing or cleaning implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
- D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
- D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
- D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
- D21H21/38—Corrosion-inhibiting agents or anti-oxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pest Control & Pesticides (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
본 발명은 지방산을 포함한 항균물티슈에 관한 것이다 The present invention relates to an antibacterial wet tissue containing fatty acids
보다 상세하게는 지방산(fatty acid) 및 카테킨 테아플로빈을 포함하여 원적외선을 방사하며 항균성을 형성하는 물티슈에 관한 것이다 More specifically, it relates to a wet tissue that emits far-infrared rays and forms antibacterial properties, including fatty acid and catechin theaflobin.
본 발명은 원적외선을 방사 및 항균성을 형성하는 물티슈를 수득하는 것으로 합성수지 직물에 지방산 및 카테킨 테이플로빈을 코팅 및 포함한다 종래의 공개특허 10-2018-0051685호 에서는 원적외선을 방사하는 광물질과 항균성 식물추출물을 물티슈에 첨가하는 방법을 개시하고 있다 등록특허 10-2288515호에서는 편백나무 및 바오밥나무 추출물을 첨가하는 방법을 개시하고 있다 The present invention is to obtain a wet tissue that emits far-infrared rays and forms antibacterial properties, and the synthetic resin fabric is coated with fatty acid and catechin taplovin. Registered Patent No. 10-2288515 discloses a method of adding cypress and baobab extracts to wet tissue.
공개특허 10-2021-0059237호 에서 글리세린 디프로필렌글라이콜 ,카프릴릴글라이콜 1,2-헥산디올 및 정제수를 , 침지시키는 방법을 개시하고 있다 등록특허10-1943522호에서는 이산화규소 이산화티탄 나노은 분말 식물성 추출액을 첨가하는 항균 물티슈의 제조방법을 개시하고 있다 Patent Publication No. 10-2021-0059237 discloses a method of immersing glycerin, dipropylene glycol, caprylyl glycol, 1,2-hexanediol, and purified water. Patent No. 10-1943522 discloses silicon dioxide, titanium dioxide, and nano-silver Disclosed is a method for manufacturing an antibacterial wet tissue in which powdered vegetable extract is added.
본 발명은 원적외선과 항균성을 형성한 물티슈를 수득하는 것으로서 지방산 중에서 선택한 1종 이상 및 카테킨 또는 테아플로빈을 포함하는 것을 목적으로 한다 An object of the present invention is to obtain a wet tissue formed with far-infrared rays and antibacterial properties, which includes at least one selected from fatty acids and catechin or theaflobin.
본 발명은 지방산에서 인체에 유익한 근적외선과 원적외선이 방사되며 항균성을 형성하는 작용기전을 발견하였고 연구한 결과 이들 지방산을 물티슈용 직물에 포함 사하여 항균성 물티슈를 수득하는 것이다 The present invention discovered a mechanism of action in which fatty acids emit near-infrared and far-infrared rays beneficial to the human body and form antibacterial properties.
지방산은(fatty acid)은 포화 지방산과 불포화 지방산으로 분류할 수 있다 화학구조는 4~24개의 탄소원자를 갖는 긴 사슬로 양쪽 끝에 카르복실기(-COOH)와 메틸기(-CH3)를 갖는 탄화수소 꼬리 형태이다 Fatty acids can be classified into saturated fatty acids and unsaturated fatty acids. Their chemical structure is a long chain with 4 to 24 carbon atoms, in the form of a hydrocarbon tail with carboxyl groups (-COOH) and methyl groups (-CH3) at both ends.
포화지방산(saturated fatty acid)은 지방산 단일 결합을 가지고 있는 지방산 이다 포화지방산은 동물성 지방에 많고 용융점이 높고 대부분 고체로 존제한다 Saturated fatty acids are fatty acids with single fatty acid bonds. Saturated fatty acids are found in animal fats, have high melting points, and are mostly solid.
불포화지방산은 생선이나 식물성 지방에 많고 용융점이 낮으며 상온에서 액체로 존제한다 예를 들어서 오메가-3 지방산은 불포화 지방산으로 리놀렌산(lonolenic acid) EPA(Eicosapentaenoic acid), DHA(Docosahexaenoicaicd) 등으로 구성된다 일반적인오메가 -3 지방산의 분자 구조에는 3가지 형태가 있다 Unsaturated fatty acids are abundant in fish and vegetable fats, have low melting points, and exist as liquids at room temperature. For example, omega-3 fatty acids are unsaturated fatty acids and are composed of linolenic acid, EPA (Eicosapentaenoic acid), and DHA (Docosahexaenoic acid). The molecular structure of omega-3 fatty acids has three forms
포화지방과 불포화지방으로 이루어진 TG(트리글리세라이드)형이 있으며 어류에서 추출한다 글리세롤 1분자에 2개의 포화지방과 1개의 불포화지방이 결합한 구조이므로 불포화지방산인 오메가-3(EPA, DHA)성분 순도가 33% 정도로 낮은 문제점이 있으며 EE(에틸에스테르)형이 있으며 생선에서 추출한 지방에 에탄올을 첨가하고 지방산을 증류를 통해서 분리하여 에탄올 1분자에 포화지방 1개와 에탄올 2분자에 불포화 지방 2개가 결합한 구조이므로 오메가-3 지방산(EPA, DHA)의 순도를 70% 정도까지 높일 수 있지만 에탄올 잔류하는 문제점이 있다There is a TG (Triglyceride) type composed of saturated and unsaturated fats, and it is extracted from fish. It has a structure in which two saturated fats and one unsaturated fat are combined in one molecule of glycerol, so the purity of unsaturated fatty acid Omega-3 (EPA, DHA) is high. There is a problem as low as 33%, and there is an EE (ethyl ester) type. Ethanol is added to fat extracted from fish, and fatty acids are separated through distillation. Since one molecule of ethanol is combined with one saturated fat and two molecules of ethanol are combined with two unsaturated fats. Although the purity of omega-3 fatty acids (EPA, DHA) can be increased to about 70%, there is a problem of remaining ethanol.
rTG(알티지)형은 EE 형태의 문제점을 개선한 것으로 EE형을 에스테르화(Re esterified)하여 글리세롤 분자 3개에 불포화 지방산 3개를 결합시킨 것으로 오메가-3 지방산(EPA, DHA)의 순도를 100%까지 농축 할 수 있지만 과다한 제조 경비가 요구되는 문제점이 있다 The rTG (Altige) type is an improvement on the problems of the EE type. The EE type is re-esterified and 3 unsaturated fatty acids are combined with 3 glycerol molecules, improving the purity of omega-3 fatty acids (EPA, DHA). It can be concentrated up to 100%, but there is a problem in that excessive manufacturing costs are required
본 발명에서 사용하는 지방산은 오메가-3 지방산,오메가-9 지방산 오메가-6 지방산을 사용하는 것이 바람직하며 순도가 높을수록 항균성과 높으며 원적외선을 방사한다 예를 들어서 순도 50~ 75% 오메가-3 지방산 0.1 ~ 5중량부를 포함한 폴리프로필렌계 물티슈는 KFIA-F1-1005 시험에서 37℃에서 원적외선 방사율(5~20μm) 0.884이며 KFiA-F1-1003 시험에서 대장균 초기농도(CFU-ml)8.8x10~대장균 정균감소율 87(%),포도상구균 초기농도(CFU-ml)1.6x10⁴감소율78.7(%)이며 As for the fatty acids used in the present invention, it is preferable to use omega-3 fatty acids, omega-9 fatty acids, and omega-6 fatty acids. The higher the purity, the higher the antibacterial properties and far-infrared radiation. ~ 5 parts by weight of the polypropylene wipes had a far-infrared ray emissivity (5-20 μm) of 0.884 at 37°C in the KFIA-F1-1005 test, and an initial concentration of E. coli (CFU-ml) of 8.8x10 ~ E. coli bacteriostatic reduction in the KFiA-F1-1003 test 87 (%), Staphylococcus aureus initial concentration (CFU-ml) 1.6x10⁴ reduction rate 78.7 (%)
순도 85~95% 오메가-3지방산 0.1 ~ 5중량부를 포함한 폴리프로필렌계 물티슈는 KFIA-F1-1005 시험에서 37℃에서 원적외선 방사율(5~20μm) 0.885이며 KFiA-F1-1003 시험에서 대장균 초기농도(CFU-ml)8.8x10~대장균 정균감소율 95(%),포도상구균 초기농도(CFU-ml)1.6x10⁴~ 94(%)이며 The polypropylene-based wet tissue containing 0.1 to 5 parts by weight of omega-3 fatty acid with a purity of 85 to 95% has a far-infrared ray emissivity (5 to 20 μm) of 0.885 at 37 ° C in the KFIA-F1-1005 test, and the initial concentration of Escherichia coli in the KFiA-F1-1003 test ( CFU-ml) 8.8x10 ~ Escherichia coli bacteriostatic reduction rate 95 (%), Staphylococcus aureus initial concentration (CFU-ml) 1.6x10⁴ ~ 94 (%)
순도 95~99.% 오메가-3 지방산 0.5~5중량부를 포함한 폴리프로필렌 물티슈 직물은 KFIA-F1-1005 시험에서 37℃에서 원적외선 방사율(5~20μm) 0.887이며 대장균과 살모넬라균 정균감소율 99.9% 검출되지 않았으므로 오메가3의 순도는 원적외선 방사율과 항균성과 비례하는 것으로 확인 할 수 있으므로 The polypropylene wet tissue fabric containing 0.5 to 5 parts by weight of omega-3 fatty acids with a purity of 95 to 99.% has a far-infrared emissivity (5 to 20 μm) of 0.887 at 37 ° C in the KFIA-F1-1005 test, and a bacteriostatic reduction rate of Escherichia coli and Salmonella is not detected by 99.9%. Therefore, it can be confirmed that the purity of omega 3 is proportional to the far-infrared emissivity and antibacterial properties.
오메가-3 지방산의 순도가 적절하게 조절되야 함은 당 업계의 숙련된 기술자는 알수 있다 오메가 -6 오메가9 지방산도 오메가-3와 작용이 유사하므로 적절하게 혼용할 수 있다 Those skilled in the art know that the purity of omega-3 fatty acids must be appropriately controlled. Since omega-6 and omega-9 fatty acids have similar actions to omega-3, they can be appropriately mixed.
단일 불포화 지방산인 오메가-9 지방산은 지방산의 메틸기 말단부터 9번째의 탄소가 2중 결합을 갖는 일련의 지방산으로 올레산(oleic acid)이라고도 하며 올레산의 염 및 에스터는 올레이트(oleate)라고 한다. 올레산은 이중 결합을 하나 밖에 포함하고 있지 않기 때문에 다가 불포화 지방산인 리놀레산 및 리놀렌산에 비교하여 지질 산화반응이 어려우며 올리브유와 카놀라유(유채씨 기름)에 주성분으로 다량 함유되어 있다 Omega-9 fatty acids, which are monounsaturated fatty acids, are a series of fatty acids having a double bond at the ninth carbon from the terminal of the methyl group of the fatty acid, and are also called oleic acid, and salts and esters of oleic acid are called oleates. Since oleic acid contains only one double bond, it is difficult to oxidize lipids compared to polyunsaturated fatty acids, linoleic and linolenic acids, and is contained in large amounts as a main component in olive oil and canola oil (rapeseed oil).
오메가-6 지방산은 18개의 탄소로 구성된 사슬에 2개의 시스 이중 결합을 가지고 있는 지방산이다 리놀레산 이라고도 하며 다른 오메가-6 지방산 생합성의 전구물체로서 작용한다.오메가-6 지방산으로 아라키돈산(arachidonic acid) 감마(γ)-리놀렌산 등이 있다 리놀레산은 유성 페인트 및 바니시에 유용한 건성유를 만드는 데 사용되며 항염증과 여드름 감소, 피부 미백 보습 작용을 하며 환원되면 리놀레일 알코올을 생성하며 아세톤, 에탄올에 쉽게 용해된다 살리코니아유, 달맞이꽃유,멜론씨유,옥수수유,포도씨유,해바라기씨유,콩기름,올리브유에 다량 함유되어 있다 Omega-6 fatty acids are fatty acids with two cis double bonds in an 18-carbon chain, also called linoleic acid, and serve as a precursor for the biosynthesis of other omega-6 fatty acids. Arachidonic acid gamma as an omega-6 fatty acid (γ)-linolenic acid, etc. Linoleic acid is used to make a drying oil useful for oil paints and varnishes. It has anti-inflammatory and acne-reducing, skin-whitening and moisturizing properties. When reduced, it produces linoleyl alcohol and is easily soluble in acetone and ethanol It is contained in corn oil, evening primrose oil, melon seed oil, corn oil, grape seed oil, sunflower seed oil, soybean oil, and olive oil.
본 발명에서 지방산은 지질과산화 반응(Lipid peroxidation)이 발생하므로 지질과산화 반응(Lipid peroxidation)을 억제하고 항균성을 증가하기 위해 폴리페놀인 카테킨 또는 테아플라빈을 포함할 수 있다 In the present invention, since lipid peroxidation occurs in fatty acids, polyphenols such as catechin or theaflavin may be included to suppress lipid peroxidation and increase antimicrobial activity.
카테킨은 녹차에 다량 함유되 있다 녹차를 약20%~65% 발효한 것이 우롱차이며 약85%이상 발효 한 것이 홍차이다 발효과정에서 카테킨은 산화되고 테아플라빈이 생성된다 카테킨이 산화되어 퀴논이 되며 퀴논 2개가 모이면 테아플라빈이 된다 Green tea contains a large amount of catechin. About 20% to 65% of green tea is fermented as oolong tea, and about 85% or more fermented as black tea. During the fermentation process, catechin is oxidized and theaflavin is produced. When two quinones come together, they form theaflavins.
녹차를 90분 발효 진행하면 에피갈로카테킨갈레이트는 약98% 이상 감소하고 테아플라빈으로 생성되므로 녹차 추출물 단독을 사용하거나 또는 홍차 추출물과 적절하게 혼용할 수 있다 When green tea is fermented for 90 minutes, epigallocatechin gallate is reduced by about 98% and produced as theaflavin, so green tea extract alone can be used or mixed with black tea extract.
카테킨과 홍차추출물의 테아플라빈,테아플라빈갈레이트(Theaflavingallate) 및 그 유도체의 항바이러스 항세균 작용기전은 오래전 부터 알려져 왔다 중증급성호흡기증후군(SARS-CoV - 사스) 홍차 추출물에 함유된 카테킨,테아플라빈이 효능이 있다는 연구 결과도 관련 학계에서 수차 발표되었고 2020.3.10 세계적인 의학바이러스학회지(저널 오브 메디컬 바이롤로지)에도 게제되었다 카테킨에서 생성된 태아플라빈(theaflavin),테아플라빈-3갈레이트(theaflavin-3-gallate,테아플라빈-3'-갈레이트(theaflavin-3’-gallate)테아플라빈-3,3'-다이갈레이트(theaflavine-3,3’digallate)는 우수한 항바이러스 효과가 있는 것으로 발표되고 있으며 카테킨에 비교하여 테아플라빈의 항바이러스 작용이 더 강력하다는 연구 결과도 발표되고있다 The antiviral and antibacterial mechanism of action of catechins and black tea extract's theaflavin, theaflavingallate and their derivatives has been known for a long time. The research results that theaflavin is effective have also been published several times in related academic circles and have been published in the world-class medical virology journal (Journal of Medical Virology) on March 10, 2020. Theaflavin-3-gallate (theaflavin-3'-gallate) Theaflavine-3,3'-digallate (theaflavine-3,3'-digallate) is an excellent antiviral It has been announced that it is effective, and research results have also been announced that theaflavin has a stronger antiviral action compared to catechin.
일반적인 물티슈의 제조공정에서 수분을 포함하는 제조공정은 공지된 기술로서 상세한 설명은 생략한다 In the manufacturing process of general wet wipes, the manufacturing process containing water is a well-known technology, so detailed descriptions will be omitted.
본 발명에서 지방산을 물티슈에 포함 방법은 예를 들어 폴리프로필렌계 합성수지직물 100중량부에 대하여 순도 80~99% 오메가-3 지방산, 순도 80~99%의 오메가6 지방산, 순도 80~99%의 오메가 9 지방산, 중에서 1종 이상을 선택하여 0.1~ 10중량부를 포함할 수 있으며 예를 들어서 물티슈 직물에 코팅 또는 합침하여 포함 할 수 있다 In the present invention, the method of including fatty acids in wet tissues is, for example, 80 to 99% pure omega-3 fatty acids, 80 to 99% pure omega-6 fatty acids, and 80 to 99% pure omega based on 100 parts by weight of polypropylene synthetic resin fabric. One or more fatty acids may be selected and included in an amount of 0.1 to 10 parts by weight, for example, by coating or impregnating wet tissue fabric.
바람직하게는 0.1~5중량부를 포함하며 더 바람직하게는 0.1~2중량부를 포함할수 있다 한편 카테킨, 테아플로빈(고형분기준)은 1종이상 선택하여 합성수지 직물에 대하여 0.001~ 10중량부를 포함할 수 있으며 바람직하게는 0.001~ 5중량부 더 바람직하게는 0.001~2중량부를 포함한다 카테킨, 테아플로빈은 지방산의 산화를 방지하며 물티슈에 항균성 항바이러스성을 형성한다 포함하는 방법은 예를들어 지방산에 첨가할 수 있으며 물티슈 제조공정에서 수분에 첨가하여 함침하여 포함할 수 있다 It preferably contains 0.1 to 5 parts by weight, more preferably 0.1 to 2 parts by weight. Meanwhile, catechin and theafrobin (based on solid content) may contain 0.001 to 10 parts by weight based on the synthetic resin fabric by selecting one or more. and preferably 0.001 to 5 parts by weight and more preferably 0.001 to 2 parts by weight. Catechin and theafrobin prevent oxidation of fatty acids and form antibacterial and antiviral properties in wet wipes. It can be added and impregnated by adding it to moisture in the wet tissue manufacturing process.
본 발명에서 지방산과 카테킨 테아플로빈을 포함하는 방법은 다양할 수 있으며 상기에 한정되지 않는다 물티슈에 포함 할 수 있는 목적이면 방법에 제한 받지 않는다 예를 들어 카테킨을 지방산에 첨가하여 포함할 수 있고 에틸알콜 또는 수분에 첨가하여 포함할 수 있다 In the present invention, the method of including fatty acid and catechin theaflobin may vary and is not limited to the above. The method is not limited as long as it is a purpose that can be included in wet tissue. For example, catechin can be added to fatty acid and included, and ethyl Can be included by adding to alcohol or water
물티슈 직물에 대하여 지방산과 카테킨 테아플로빈의 포함이 상기 중량부 이상이면 물성의 향상은 미약하고 비경제적이며 미만이면 발명이 목적하는 구현이 부족하다If the inclusion of fatty acids and catechin theaflobin in the wet tissue fabric is more than the above parts by weight, the improvement of physical properties is weak and uneconomical, and if less than that, the implementation of the purpose of the invention is insufficient.
하기 표1은 식물성 지방산의 성분표 이며 표2는 포화지산방산 오메가-9 지방산 오메가-6 지방산 오메가-3 지방산의 화학식을 의미한다Table 1 below shows the composition of vegetable fatty acids, and Table 2 shows the chemical formula of saturated fatty acids, omega-9 fatty acids, omega-6 fatty acids, and omega-3 fatty acids.
하기 표3은 녹차와 홍차에 함유된 EGCG이며 또는 이의 유도체를 의미한다Table 3 below shows EGCG contained in green tea and black tea or its derivatives.
하기 표4는 녹차,홍차의 테아플라빈이며 이의 유도체를 의미한다Table 4 below shows the theaflavins of green tea and black tea and their derivatives.
본 발명은 물티슈에 항바이러스 항세균 작용의 유효한 조성물인 지방산 및 카테킨 테아플로빈을 포함하여 원적외선을 관련 산업에 기여할 수 있다 The present invention can contribute far-infrared rays to related industries by including fatty acids and catechin theaflobin, which are effective compositions of antiviral and antibacterial action in wet wipes.
이하 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다 The present invention will be described in more detail through the following examples. These examples are only for explaining the present invention more specifically, and the scope of the present invention is not limited by these examples.
< 실시예 1 ><Example 1>
공지 기술인 물티슈 연속 제조공정에서 폴리프로필렌계 직물 100중량부에 대하여 오메가-3 지방산 (순도 95~99%) 0.5 ~3 중량부를 분무하여 물티슈 직물에 포함 시켰고 공지의 제조방법으로 물티슈를 수득하였다 In a known wet tissue manufacturing process, 0.5 to 3 parts by weight of omega-3 fatty acid (purity 95 to 99%) was sprayed with respect to 100 parts by weight of polypropylene-based fabric, and included in the wet tissue fabric, and wet tissue was obtained by a known manufacturing method.
< 실시예 2 ><Example 2>
[실시예 1과 동일하게 항균성 물티슈를 제조하였고 오메가-6로 대체하였다 [An antibacterial wet tissue was prepared in the same way as in Example 1 and replaced with omega-6
< 실시예 3 ><Example 3>
실시예 1과 동일하게 물티슈를 제조하였고 오메가-9로 대체하였다 Wet tissue was prepared in the same manner as in Example 1 and replaced with omega-9.
< 실시예 4 ><Example 4>
실시예 1과 동일하게 물티슈를 제조하였고 오메가-9 오메가-3를 65:35로 혼합하여 포함하였다 Wet tissue was prepared in the same manner as in Example 1, and omega-9 and omega-3 were mixed and included at a ratio of 65:35.
< 실시예 5><Example 5>
실시예 1내지 4와 동일하게 실시하였고 테아플로빈 0.00~2중량부 포함하였다 It was carried out in the same manner as in Examples 1 to 4, and included 0.00 to 2 parts by weight of theafrobin.
< 비교예 1 ><Comparative Example 1>
지방상 및 카테킨 테아플로빈이 포함되지 않은 증류수 방부제 에틸알콜이 포함된 물티슈와 물성을 비교 하였다 Physical properties were compared with wet tissues containing distilled water preservative ethyl alcohol that did not contain fatty phase and catechin theaflobin.
KFIA-F1-1005 KFiA-F1-1003
KFIA-F1-1005
(CFU-ml)8.8x10~E. coli initial concentration
(CFU-ml)8.8x10~
(CFU-ml)1.6x10⁴Staphylococcus initial concentration
(CFU-ml)1.6x10⁴
(5~20μm) Far Infrared Emissivity
(5~20μm)
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230101300A KR20240018397A (en) | 2021-08-22 | 2023-08-02 | Antimicrobial wipes that emit far-infrared radiation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20210110590 | 2021-08-22 | ||
KR1020210110590 | 2021-08-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230028706A true KR20230028706A (en) | 2023-03-02 |
Family
ID=85508990
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220096427A KR20230028706A (en) | 2021-08-22 | 2022-08-02 | Antimicrobial wipes that emit far-infrared radiation |
KR1020230101300A KR20240018397A (en) | 2021-08-22 | 2023-08-02 | Antimicrobial wipes that emit far-infrared radiation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230101300A KR20240018397A (en) | 2021-08-22 | 2023-08-02 | Antimicrobial wipes that emit far-infrared radiation |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR20230028706A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180051685A (en) | 2016-11-07 | 2018-05-17 | 황덕현 | Far Infrared deodorization Antibacterial functional baby wipes Adult and mask pack manufacturing method |
KR101943522B1 (en) | 2018-06-04 | 2019-01-29 | 추병순 | Manufacturing method for antimicrobial wet tissue and antimicrobial wet tissue manufactured by the same |
KR20210059237A (en) | 2019-11-15 | 2021-05-25 | (주)다사요윙윙 | Cleaning tissue based on anti ammonia composition, and manufacturing method thereof |
KR102288515B1 (en) | 2021-03-15 | 2021-08-10 | 주식회사 가인인터내셔널 | Antibacterial wettissue |
-
2022
- 2022-08-02 KR KR1020220096427A patent/KR20230028706A/en unknown
-
2023
- 2023-08-02 KR KR1020230101300A patent/KR20240018397A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180051685A (en) | 2016-11-07 | 2018-05-17 | 황덕현 | Far Infrared deodorization Antibacterial functional baby wipes Adult and mask pack manufacturing method |
KR101943522B1 (en) | 2018-06-04 | 2019-01-29 | 추병순 | Manufacturing method for antimicrobial wet tissue and antimicrobial wet tissue manufactured by the same |
KR20210059237A (en) | 2019-11-15 | 2021-05-25 | (주)다사요윙윙 | Cleaning tissue based on anti ammonia composition, and manufacturing method thereof |
KR102288515B1 (en) | 2021-03-15 | 2021-08-10 | 주식회사 가인인터내셔널 | Antibacterial wettissue |
Also Published As
Publication number | Publication date |
---|---|
KR20240018397A (en) | 2024-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100483247B1 (en) | Conjugated linolenic acid-based synthetic triglycerides | |
EP1838171B1 (en) | Production and use of an antioxidant extract from crypthecodinium sp | |
JP2017006123A (en) | Method for improving or maintaining stable state in edible oil oxidation reaction | |
TW200417595A (en) | Composition containing organic substance having double bond with improved oxidation stability | |
JP2007530624A (en) | Topical formulation for use on the skin, containing natural oils of evening primrose (Oenothera Biennis) and osmolytes derived from extreme environmental microorganisms | |
Avato et al. | Rare fatty acids and lipids in plant oilseeds: Occurrence and bioactivity | |
US20120219647A1 (en) | Antioxidant composition | |
US10501705B2 (en) | Method of processing edible oil | |
JP5765476B2 (en) | Edible vegetable oil containing polyunsaturated fatty acids | |
JPH02189394A (en) | Oil and fat composition | |
CN114176139B (en) | Lipid composition and application thereof | |
KR20230028706A (en) | Antimicrobial wipes that emit far-infrared radiation | |
JPWO2016067804A1 (en) | Oil containing fat with long-chain polyunsaturated fatty acid and food containing the same | |
JP2017221143A (en) | Acidic oil-in-water emulsified food | |
Zhao et al. | Extraction and characterization of Raphanus Sativus seed oil obtained by different methods | |
FR2933850A1 (en) | Antioxidant composition, useful to stabilize polyunsaturated oils, comprises a blend of abietic acid derivative (carnosic acid) and polyphenol extracts from green tea, dispersed in a oily vehicle | |
KR20200116364A (en) | Emulsified oil composition for inhibiting formation of an unpleasant taste and odor comprising oil containing polyunsaturated fatty acids, foods comprising the same, and methods of preparing the same | |
DE2339149A1 (en) | Partial esters of aliphatic polyols - and alpha-branched aliphatic monocarboxylic acids, used as water-in-oil emulsifiers for cosmetics | |
US20240023570A1 (en) | Oil-in-water emulsified composition | |
WO2017042340A1 (en) | Process of production of a formulation comprising therapeutically active or nutritious plant extracts | |
JP2021101663A (en) | Oil/fat composition, method for enhancing hygienic property of food, and method for producing food | |
US2681283A (en) | Stabilized fatty compositions and stabilizers therefor | |
JP2022040824A (en) | Bacteriostatic agent | |
EP4305133A1 (en) | Compositions and methods for preventing or reducing autoxidation of fragrance and food oils | |
JP2022120970A (en) | Method for suppressing cooked odor of oil and fat composition |